Mupirocin News
Biofilms: Recent Study Supports Elimination of Biofilm Colonies; Sinus Patients may Benefit
Aerosol Science Laboratories (ASL Pharmacy) announces today a new formula for topical sinus use containing mupirocin. Mupirocin has been proven effective against biofilms in in vitro clinical studies.
GSK Receives Approvable Letter for Topical Antibiotic, Altabax™ (retapamulin ointment), 1%
GlaxoSmithKline (GSK) announced today that the U.S. Food and Drug Administration has issued an approvable letter for its topical antibacterial, Altabax (retapamulin ointment), 1%, for the treatment of secondarily-infected...
Replidyne Commences Clinical Trials For REP8839
Replidyne, Inc. (Nasdaq: RDYN) announced today the initiation of Phase I clinical testing of its topical anti-infective drug candidate REP8839, being developed for treatment of skin and wound infections and the prevention of S....
Replidyne enters clinical testing
Replidyne Inc. has initiated Phase I clinical testing of its topical anti-infective drug candidate REP8839, which is being developed for treatment of skin and wound infections, the company said Tuesday.
New Topical Antibiotic May Inhibit Skin Infections in Humans
Researchers from Colorado have identified a new topical antibiotic that may inhibit skin infections in humans. Their findings appear in the October 2005 issue of the journal Antimicrobial Agents and Chemotherapy.